INFU: InfuSystem Inc Projected Price to Earnings

Brandmark of infusystem.com (INFU)

The InfuSystem Holdings (INFU) business model is based on providing services and leasing infusion systems, focusing on palliative care and oncology. The company creates comprehensive technical solutions for clinics, which guarantees a steady cash flow. The current PE ratio is 24.20. The market trend in share price complements data on disciplined management, which successfully optimizes capital movement and logistics.

INFU - infusystem.com Market Cap to Projected Earnings over the range 07/04/2022 - 11/13/2026

Analytical breakdowns and data insights for company InfuSystem Inc (INFU)

- stock value and consensus price forecast:
Summary company analysis:INFU InfuSystem Holdings, Inc.
Signature product of infusystem.com

A complex accreditation system and the high cost of staff retraining in clinics provide InfuSystem Holdings (INFU) with a steady revenue stream. The ratio of current market capitalization to expected earnings allows for the valuation of this competitive advantage per dollar of future income. Investors utilize this metric to determine if the asset is overbought or to identify an entry point when the business is undervalued. Analyzing market optimism is simplified through the company's forward P/E ratio. The dynamics of this indicator reveal the real cost of expected growth amid uncertainty.

Direct competitors

Future Price to Earnings Intuitive (ISRG)|Future Price to Earnings DHR (Danaher Corporation)|Becton, Dickinson and Company - Projected Price to Earnings|Future Price to Earnings Multiple STE|West Pharmaceutical Services - Forward P/E Multiple|Market Cap to Projected Earnings baxter.com BAX|Masimo (MASI) - Future Price to Earnings|Price to Future Earnings Ratio STVN|Future Price to Earnings Teleflex Inc|Merit Medical Corp (MMSI) - Market Cap to Projected Earnings|Projected Price to Earnings NVST (Envista Holdings)|Market Cap to Future Earnings Ratio ICUI|Future Price to Earnings Dentsply Sirona XRAY|Future Price to Earnings Multiple LMAT|ATRC: Projected Price to Earnings|STAA - Forward P/E Multiple|niagenbioscience.com (NAGE) - Future Price to Earnings|Projected Price to Earnings zimvie.com|ANGO (AngioDynamics) - Forward P/E Multiple|Projected Price to Earnings Ratio Cerus Corp. CERS|Future Price to Earnings Alpha Teknova Inc (TKNO)|Monogram Orthopedics Inc. - Price to Future Earnings Ratio|Sharps Technology - Projected Price to Earnings|Market Cap to Future Earnings Ratio UTMD (utahmed.com)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah SA NYXH|MBOT: Forward P/E Multiple|PDEX - Market Cap to Projected Earnings|Future Price to Earnings Zentek Ltd.|Price to Future Earnings Ratio ELUT (elutia.com)|Forward P/E Multiple MLSS|NXGL: Price to Expected Earnings Ratio|Retractable Technologies, Inc. - Projected Price to Earnings|Forward P/E Multiple harvardbioscience.com HBIO|FEMY - Future Price to Earnings|Market Cap to Projected Earnings MeihuaMed MHUA|POAI (predictive-oncology.com) - Projected Price to Earnings|Projected Price to Earnings Ratio Callan JMB (CJMB)|Future Price to Earnings Atrion Corp|NeuroMetrix Corporation (NURO) - Market Cap to Projected Earnings